

































































Diagnosis and treatment of neurogenic
dysphagia – S1 guideline of the German
Society of Neurology
Rainer Dziewas1,2* , Hans-Dieter Allescher3, Ilia Aroyo4, Gudrun Bartolome5, Ulrike Beilenhoff6, Jörg Bohlender7,
Helga Breitbach-Snowdon8, Klemens Fheodoroff9, Jörg Glahn10, Hans-Jürgen Heppner11, Karl Hörmann12,
Christian Ledl13, Christoph Lücking14, Peter Pokieser15, Joerg C. Schefold16, Heidrun Schröter-Morasch17,
Kathi Schweikert18, Roland Sparing19, Michaela Trapl-Grundschober20, Claus Wallesch21, Tobias Warnecke1,
Cornelius J. Werner22, Johannes Weßling23, Rainer Wirth24 and Christina Pflug25
Abstract
Introduction: Neurogenic dysphagia defines swallowing disorders caused by diseases of the central and peripheral
nervous system, neuromuscular transmission, or muscles. Neurogenic dysphagia is one of the most common and at
the same time most dangerous symptoms of many neurological diseases. Its most important sequelae include
aspiration pneumonia, malnutrition and dehydration, and affected patients more often require long-term care and
are exposed to an increased mortality. Based on a systematic pubmed research of related original papers, review
articles, international guidelines and surveys about the diagnostics and treatment of neurogenic dysphagia, a
consensus process was initiated, which included dysphagia experts from 27 medical societies.
Recommendations: This guideline consists of 53 recommendations covering in its first part the whole diagnostic
spectrum from the dysphagia specific medical history, initial dysphagia screening and clinical assessment, to more
refined instrumental procedures, such as flexible endoscopic evaluation of swallowing, the videofluoroscopic
swallowing study and high-resolution manometry. In addition, specific clinical scenarios are captured, among others
the management of patients with nasogastric and tracheotomy tubes. The second part of this guideline is
dedicated to the treatment of neurogenic dysphagia. Apart from dietary interventions and behavioral swallowing
treatment, interventions to improve oral hygiene, pharmacological treatment options, different modalities of
neurostimulation as well as minimally invasive and surgical therapies are dealt with.
Conclusions: The diagnosis and treatment of neurogenic dysphagia is challenging and requires a joined effort of
different medical professions. While the evidence supporting the implementation of dysphagia screening is rather
convincing, further trials are needed to improve the quality of evidence for more refined methods of dysphagia
diagnostics and, in particular, the different treatment options of neurogenic dysphagia. The present article is an
abridged and translated version of the guideline recently published online (https://www.awmf.org/uploads/tx_
szleitlinien/030-111l_Neurogene-Dysphagie_2020-05.pdf).
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Introduction
The present article is an abridged and translated version
of the guideline recently published online (https://www.
awmf.org/uploads/tx_szleitlinien/030-111l_Neurogene-
Dysphagie_2020-05.pdf). The act of swallowing is a
highly complex neuromuscular process that requires
precise bilateral coordination of more than 25 muscle
pairs. Using different imaging techniques, numerous
physiological studies have consistently demonstrated
that apart from the well-established role of the brain
stem, different cortical areas are involved in the modula-
tion of swallowing. Based on these findings,
reorganization mechanisms have been further explored
and form the neuroscientific basis for treatment ap-
proaches using different neurostimulation modalities.
Neurogenic dysphagia defines swallowing disorders
caused by diseases of the CNS, PNS, neuromuscular
transmission, or muscles. In contrast to this uniformity
suggestive term, swallowing disorders caused by specific
diseases differ considerably in terms of their clinical
presentation, the respective therapeutic options, and the
prognosis. Dysphagia is one of the most common and at
the same time most dangerous symptoms of many
neurological diseases. Impaired deglutition is initially
found in at least 50% of all patients with ischemic or
hemorrhagic stroke [1]. Affected patients have a 4 times
increased risk of aspiration pneumonia, suffer more
often from a long-lasting severe disability, are more
often discharged to nursing homes, and also show sig-
nificantly increased mortality [2]. Comparable numbers
have been published for traumatic brain injury with a re-
ported incidence of clinically relevant dysphagia in about
60% of patients [3]. In this patient collective, the pres-
ence of dysphagia is associated with a significantly ex-
tended time on mechanical ventilation and a longer
need for artificial nutrition. In all Parkinson syndromes,
neurogenic dysphagia is also a major risk factor for
pneumonia, which is the leading cause of death in these
patients [4, 5]. Furthermore, swallowing disorders in
these patients are associated with a reduced quality of
life, insufficient drug effects, and malnutrition [6, 7]. 20-
30% of patients with dementia have severe dysphagia
with silent aspiration that goes unnoticed by the patients
[8]. Dysphagia is also a prominent clinical feature in
various neuromuscular diseases. Up to 30% of patients
with amyotrophic lateral sclerosis present with impaired
swallowing at diagnosis [9] and practically all of them
develop dysphagia as the disease progresses. Myasthenia
Gravis manifests itself in 15% of cases with swallowing
impairments. As the illness progresses, over 50 % of all
patients are affected, and in more than 50 % of cases, a
myasthenic crisis is preceded by dysphagia [10]. In mul-
tiple sclerosis, dysphagia occurs in more than one-third
of patients and is linked to increased morbidity and
mortality [11]. Patients with inflammatory muscle disor-
ders are also often subject to swallowing impairment.
The frequency is approximately 20 % in dermatomyo-
sitis, 30–60 % in polymyositis, and between 65 and 86 %
in inclusion body myositis [12]. Finally, dysphagia is also
a major diagnostic and therapeutic challenge in the in-
tensive care unit [13]. Regardless of the primary illness,
70–80 % of patients requiring prolonged mechanical
ventilation present, at least temporarily, with significant
swallowing impairment and aspiration after successful
weaning, probably due to a critical illness polyneurop-
athy and structural changes caused by the artificial air-
way like edema of the arytenoids [14]. This impairment
not only necessitates prolonged artificial nutrition, but is
also linked to serious complications, such as pneumonia
and the necessity for reintubation and is in addition an
independent predictor of increased mortality [13].
Regardless of the underlying diseases, the risk of devel-
oping a swallowing disorder increases significantly with
age. Thus, dysphagia is found in 30-40% of independently
living older people [15], while more than 50% of nursing
home residents [16] and approximately 70% of all geriatric
in-patients are affected by this disorder [17]. As with other
patient groups, in geriatric patients dysphagia increases
the risk of pneumonia and malnutrition [18] with the crit-
ical consequences of reduced physical and mental capabil-
ities and, ultimately, increased frailty [19].
Finally swallowing disorders can also occur as a side
effect of pharmacotherapy or at least be critically wors-
ened [20]. First of all, both typical and atypical neurolep-
tics may cause dysphagia which may occur as either
bradykinetic or dyskinetic form [21]. As shown in a re-
cent systematic review, there is a dose-response relation-
ship between the dosage of neuroleptic medication and
the risk of pneumonia [22]. Also, treatment with benzo-
diazepine receptor agonists is associated with an in-
creased risk of pneumonia, although the
pathophysiological link with a possible drug-induced
dysphagia for this group of substances is not clearly doc-
umented [20]. Finally, experimental studies have shown
that intravenously injection of opiates is associated with
an acute deterioration of pharyngeal swallowing function
and an increased risk of aspiration [23]. However, the
clinical significance of this finding is still unclear, since
in recently extubated intensive care patients, for ex-
ample, the occurrence of silent aspirations did not cor-
relate with the cumulative opiate dose [24].
This guideline addresses general issues regarding diag-
nosis and treatment of neurogenic dysphagia. More
disease-specific topics are covered in respective guideline
chapters (diagnosis of acute cerebrovascular diseases;
Idiopathic Parkinson syndrome, Diagnosis and therapy
of Myasthenia Gravis and Lambert-Eaton syndrome,
etc.). For specific questions regarding nutritional therapy
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and tube feeding, the S3 guideline “Clinical Nutrition in
Neurology” of the German Society for Nutritional Medi-
cine (DGEM) [25] and the guideline “Clinical nutrition
in neurology” of the European Society for Clinical Nutri-
tion and Metabolism (ESPEN) offer further information
[26]. The topic of hypersalivation, which is often relevant
in the treatment of dysphagia patients, is addressed in
the S2k guideline of the German Society for Otolaryn-
gology, Head and Neck Surgery which is summarized
below [27].
Methods of guideline development
This S1 level guideline (AWMF-registry number 030/
111) is based on a systematic pubmed search. Where
possible, the following sources were used: prospective
randomized intervention studies, case-control studies,
cohort studies, systematic meta-analysis, Cochrane re-
views and guideline publications. In addition, the
Cochrane Library was browsed for systematic reviews on
the subject of dysphagia. Further references have been
added as part of the review process by the guidelines
committee. The following search terms were used for
the literature search in pubmed (period 01.01.1990 to
30.06.2020).
Diagnostics: dysphagia OR swallowing disorder AND
screening OR clinical swallow evaluation OR evaluation
OR assessment OR fiberoptic endoscopic evaluation of
swallowing OR flexible endoscopic evaluation of swal-
lowing OR FEES OR videofluoroscopic swallowing study
OR VFSS OR modified barium swallow OR MBS OR
manometry OR ultrasound OR magnetic resonance im-
aging OR MRI OR computed tomography OR CT.
Therapy: dysphagia OR swallowing disorder AND be-
havioral intervention OR fluid thickening OR modifica-
tion or modification OR nutrition OR nasogastric tube
OR percutaneous endoscopic gastrostomy OR oral hy-
giene OR oral health OR neurostimulation OR neuro-
muscular electrical stimulation OR NMES OR
transcranial direct current stimulation OR tdcs OR re-
petitive transcranial magnetic stimulation OR rtms OR
pharyngeal electrical stimulation OR electrical
pharyngeal stimulation OR PES OR pharmacological
treatment OR capsaicin OR TRPV OR dopaminergic OR
amantadine OR angiotensin-converting enzyme inhibitor
OR ACE-inhibitor OR decannulation.
Consensus-building procedures. The guideline was
first drafted by the two guideline coordinators after ver-
bal agreement and informal consensus-finding of the
parties involved in the preparation of the guidelines. The
entire guideline group communicated via email to form
the consensus subsequently. The recommendations were
graded based on the available scientific evidence from
“can” as lowest, through “should” to “must” as the high-
est recommendation strength.
This guideline has been adopted by the guidelines
commission of the German Society of Neurology (DGN)




Recommendation 1: Taking the medical history
should focus on general aspects, dysphagia-specific
topics and dysphagia-related complications.
Recommendation 2: The use of specific question-
naires is recommended in addition to the carefully
guided history interview.
A detailed medical history should be taken during the
examiner’s initial contact with the patient. The examiner
gets a general impression of the patient’s condition, vigi-
lance and cognition, communication ability, and ex-
pected compliance during the further diagnostic workup.
In addition to the patient’s awareness of the disorder
(which is often diminished, for example, in the case of a
pronounced oral and/or pharyngeal sensory deficit),
these factors are important prognostic criteria and
equally relevant for the assessment of the patient’s thera-
peutic capacity. If the patient cannot provide informa-
tion himself or self-perception is limited, relatives are
the most important source of information. It is also in-
dispensable to review the medical records, especially re-
garding swallowing problems and results of previous
diagnostic or therapeutic interventions. Information on




– medications (especially neuroleptics, recent dose
changes)





Subsequently, dysphagia-specific issues are clarified:
– changes in eating and drinking behavior
– avoidance of certain foods and consistencies
– difficulty taking medication
– time needed for a meal
– posture during eating
– difficulties with chewing
– food residues after swallowing in the oral cavity or
throat
– feeling of “food sticks in the throat”
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– globus sensation (either during eating or
independently from food intake)
– voice change
– throat clearing, coughing or shortness of breath
during the meal or shortly thereafter
– oral regurgitation of the bolus
– nasal regurgitation
– temporal dimension of symptom development (acute,
subacute, chronic progressive, chronic recurrent)
– subjectively perceived localization of dysphagia (oral,
pharyngeal, oesophageal)
– Relation to certain conditions such as physical or
psychological stress, time of day
In addition, it is necessary to ask specifically about
possible complications of dysphagia:
– occurrence of pneumonia, bronchopulmonary
infections and infections of undetermined source
– dehydrations
– weight loss (always determine height, weight, BMI).
Standardized questionnaires can be used for systemat-
ically taking the medical history. For example, for TBI
patients, “Anamnesebogen zur klinischen Erfassung von
Schluckstörungen nach Hirnverletzung” is available [28].
In order to detect dysphagia symptoms more quickly,
the EAT-10 (Eating Assessment Tool) was developed
and validated for various patient groups, including
amyotrophic lateral sclerosis (ALS), COPD and head and
neck tumors [29]. Various validated questionnaires are
available to assess quality of life impairments caused by
the swallowing disorder. McHorney developed the Swal-
lowing Quality of Life (SWAL-QOL) questionnaire [30].
The Swallowing Disturbance Questionnaire (SDQ) de-
signed for use in Parkinson's patients has meanwhile
been successfully tested in a cohort of patients with
mixed dysphagia etiologies [31, 32].
Aspiration screening
Recommendation 3: Standardized aspiration screen-
ing should be performed in neurological patients.
Recommendation 4: The evaluation of a negative
screening result should be made in the context of other
clinical variables. If these indicate an increased risk of
dysphagia, a further dysphagia assessment should be
carried out in spite of the inconspicuous screening.
Recommendation 5: If neurological patients are ad-
mitted to hospital due to an acute neurological dis-
ease or due to an acute exacerbation of a pre-existing
neurological disease, aspiration screening should be
carried out as soon as possible and should therefore
ideally be implemented in the initial diagnostic
algorithm.
Recommendation 6: Water swallow tests and multi-
consistency tests are available for aspiration screen-
ing. The choice of the optimal test procedure should
be made taking into consideration other factors, such
as patient characteristics and the availability of fur-
ther dysphagia diagnostics.
Recommendation 7: Pulse oxymetry should not be
used for aspiration screening.
The aim of the aspiration screening is to quickly and
reliably identify patients at risk of aspiration by simple
means in order to initiate prophylactic measures and
further diagnostics. Screening procedures should be de-
signed in a way that they can be carried out after appro-
priate training by different health-care workers also
without extensive previous dysphagia-specific training.
Most of the published test protocols have been evaluated
in stroke patients, but also in mixed patient cohorts, and
are characterized by relatively high sensitivity (> 80%,
partly >90%) and moderate specificity at best (usually <
60%). In numerous reviews and meta-analyses, almost
exclusively dedicated to stroke patients, the various
screening tests have been evaluated and compared.
However, because comparative studies are missing so
far, the optimal test paradigm has not been determined
yet [33, 34]. Methodologically, the screening methods
can be differentiated into the following three categories,
(i) water swallowing tests, (ii) multi consistency tests,
(iii) swallow provocation test. The relevance of pulse
oxymetry for detection of aspiration is considered to be
low, despite its use in various test protocols , since stud-
ies have demonstrated that a decline in oxygen satur-
ation of >3% was neither predictive nor sensitive for
aspiration [35].
Over the past few decades, a variety of water swallow-
ing tests has (WST) been published and validated mainly
in stroke patients. These tests generally evaluate whether
the patient can drink a defined amount of water without
clinical signs of aspiration. The result of the WST is al-
ways binary; either the patient has clinical signs of aspir-
ation necessitating NPO (nil per os) and subsequently
more refined diagnostics, or the test is inconspicuous,
after which oral intake is possible. In contrast to the
WST, multi-consistency tests (such as the “Gugging
Swallowing Screen” [36] or the Volume-Viscosity Test
[37] evaluate besides liquids also other consistencies and
therefore allow for a graded stepwise rating of swallow-
ing impairment and usually add dietary recommenda-
tions to their risk assessments. The “Swallow
Provocation Test” exclusively examines the involuntary
swallowing reflex and thereby focusses on the
pharyngeal phase of deglutition. This test may be an al-
ternative in non-cooperative patients who cannot receive
an oral bolus [38]. Despite the considerable methodo-
logical differences between WST and multi-consistency
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tests there are no comparative studies of these screening
approaches available. In everyday clinical practice, the
use of a WST is considered when the evaluation of swal-
lowing safety has priority and a further assessment of
the swallowing function (see below) is available in a very
short period of time. A multi-consistency test on the
other hand is preferred if, in addition to the safety of
swallowing, swallowing efficiency is also to be assessed
and a more differentiated swallowing assessment for de-
termining the optimal oral diet is not available within a
reasonable time frame. As an example for this reasoning,
the volume viscosity test is used as central element
within an algorithm for dysphagia management of geri-
atric patients that can be flexibly adapted to the avail-
ability of further diagnostic procedures [39]
Due to the inherent possibility of false-negative screen-
ing results, in patients with negative screening tests
other clinical variables should be additionally considered.
The DGEM guideline “Clinical Nutrition in Neurology”
for example, recommends further dysphagia assessment
in stroke patients with negative screening, if the patient
presents with other predictors of a dysphagia such as a
severe neurological deficit, severe dysarthria or aphasia
or a severe facial palsy [25]. In addition, this aspect has
to be considered in groups of patients with a high risk of
silent aspiration, such as Parkinson's disease [4].
The fundamental impact of a simple aspiration
screening in patients with neurogenic dysphagia has
been studied in recent years, especially in the con-
text of acute stroke. In several prospective observa-
tional studies, the implementation of an aspiration
screening was associated with a reduction of in-
fectious complications [40]. In a prospective,
multicenter observational study Hinchey and col-
leagues demonstrated that institutions that had
established a formal aspiration screening showed
significantly lower pneumonia and mortality
rates than those without such an algorithm [41].
A recently conducted pre-post comparison
showed that the implementation of a nurse-based
aspiration screening resulted in a 50% reduction
of pneumonia rates in stroke survivors [42]. Fi-
nally, in a large, retrospective register study with
more than 60,000 patients, performing an aspir-
ation screening after stroke was found to be
time-critical. Thus, the risk of developing pneu-
monia was linearly linked to the latency of
screening and increased from just over 3% with
prompt clinical examination to almost 4.5% when
testing was done later than 24 hours [43]. A sec-
ond, methodologically similar study also de-
scribed this association between delayed
performance of aspiration screening and in-
creased risk of pneumonia [44].
Dysphagia-Assessment
Recommendation 8: The clinical swallowing examin-
ation should be based on validated protocols.
Recommendation 9: The dysphagia assessment
should include a clinical swallowing examination and
instrumental diagnostics, especially in the case of un-
clear patho-mechanism and/or unclear assessment of
swallowing safety and swallowing efficacy.
Recommendation 10: FEES and VFSS are comple-
mentary methods of instrumental dysphagia assess-
ment and should therefore, ideally, be both available.
Recommendation 11: FEES should preferably be
used for bedside examinations in severely motor-
impaired, bedridden or uncooperative patients.
Recommendation 12: FEES should preferably be
used for the assessment of pharyngeal secretion man-
agement and for the assessment of laryngeal and
pharyngeal sensitivity.
Recommendation 13: Pathological structural find-
ings determined by FEES are to be demonstrated to a
specialist (ENT or phoniatrician).
Recommendation 14: VFSS should be used prefera-
bly for the differentiated assessment of the
pharyngeal and oesophageal phase of the swallowing,
in particular in suspected disorders of the upper
esophagus sphincter.
Recommendation 15: Manometry should be used as
a complementary diagnostic tool to evaluate the
function of the upper and lower oesophageal sphinc-
ter and in suspected esophageal motility disorders.
Recommendation 16: The evaluation of the swal-
lowing act by sonography, MRI, CCT or EMG can be
performed in the context of scientific studies and is
not yet part of routine diagnostics.
Recommendation 17: In the context of dysphagia
management, consistency-specific swallowing safety
and swallowing efficacy should be determined by clin-
ical and instrumental diagnostics using validated scores.
Recommendation 18: The clarification of an etiologic-
ally undetermined dysphagia requires an interdisciplin-
ary diagnostic work-up in which, depending on the
clinical constellation, neurologists, ENTs, phoniatri-
cians, speech language pathologists, geriatricians, gas-
troenterologists, and radiologists should be involved.
Recommendation 19: In case of dysphagia of unclear
origin, the phenomenological pattern of the swallow-
ing impairment should be described as precisely as
possible by means of clinical and instrumental investi-
gations in order to obtain information about its eti-
ology and to enable a targeted diagnostic work-up.
Recommendation 20: In addition to assessing the
swallowing of different food consistencies and quan-
tities, in dysphagia patients in need of oral medica-
tion, pill swallowing should be routinely evaluated as
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part of instrumental diagnostics and the individually
optimal formulation should be identified.
Recommendation 21: In general, an inserted naso-
gastric tube does not affect the swallowing act and
should, therefore, not be removed by default for dys-
phagia diagnostics and related treatment.
Recommendation 22: Patients with a tracheal can-
nula should be managed by a multi-professional team.
Recommendation 23: In tracheotomized patients
with the therapeutic aim of decannulation, swallowing
function, oropharyngeal secretion management, vigi-
lance and ability to cooperate, respiratory function,
and airway anatomy, the voluntary and reflexive
cough, as well as the amount, nature and clearing of
the bronchial secretion, should be evaluated regularly.
Recommendation 24: In tracheotomized patients,
swallowing function should be evaluated with FEES
and in particular the parameters “secretion manage-
ment”, “spontaneous swallowing rate”, and “laryngeal
sensitivity” should be investigated.
Recommendation 25: In tracheotomized patients,
the location, fit and patency of the cannula, presence
of granulation tissue and the placement of any exist-
ing fenestration should be checked regularly.
Recommendation 26: If patients are intended to be
weaned gradually from the tracheal cannula, a
physiological air flow through the upper airway
should be established to improve pharyngo-laryngeal
sensitivity. Therefore, if possible in the clinical con-
text, the tracheal cannula’s cuff should be intermit-
tently deflated and the cannula be capped or a one-
way speaking valve used.
Recommendation 27: During gradual weaning of
the tracheal cannula, if necessary in the clinical con-
text, the diameter of the inner cannula should be
downsized to reduce the airway resistance.
Recommendation 28: A definitive decannulation is
usually possible if the cannula’s cuff can be continu-
ously deflated with the cannula simultaneously being
capped for 24-48 h without complications
Clinical swallowing examination
The detailed clinical swallowing examination (CSE) falls
within the domain of appropriately trained speech and
language therapists (SLTs). In addition to the assessment
of the aspiration risk, the CSE also provides as accurate
an assessment of the severity and phenomenological pat-
tern of the swallowing impairment as possible as a basis
for further diagnostics, dietary recommendations, and
treatment planning. After taking the medical history (see
above) and testing the patient’s attention and ability to
cooperate, oropharyngeal structures, including oral hy-
giene and dental status, the function of the caudal cra-
nial nerves, secretion and saliva management,
respiratory-swallow coordination, voluntary and reflexive
cough, voice function and voice quality, laryngeal motil-
ity, oropharyngeal sensitivity, and spontaneous swallow-
ing frequency are examined. Thereafter, swallowing tests
with different consistencies, usually in the order of soft,
liquid, and solid, are performed. In the case of patho-
logical findings, swallowing maneuvers are applied to
improve the safety and efficacy of the swallow [45]. Vari-
ous protocols are available for systematic examination
and documentation of findings, e.g. the Bogenhausen
Dysphagia Score (BODS) [46] or the “Mann-Assessment
of Swallowing Ability (MASA)” [47].
Despite its widespread use in everyday clinical practice,
the validity of the CSE is limited [48]. Leder and col-
leagues, for example, found in a cohort of acute stroke
patients that the CSE has a relatively good sensitivity of
86% for the determination of aspiration risk, but, due to
a specificity of just 30%, does not allow for any reliable
conclusion with regards to the presence of an undis-
turbed swallowing act [49]. In a study by McCullough
et al., both the intra- and the interrater reliability of
most of the parameters collected in the CSE were insuf-
ficient [50]. Rangarathnam and McCullough showed in a
cohort of 60 patients with post-stroke dysphagia that the
findings of the CSE matched those of VFSS only for la-
ryngeal elevation while other parameters of swallowing
physiology (e.g. oral transit, swallowing reflex latency,
total duration of swallowing act) are not correctly
assessed. Remarkably, in the same study, the dietary rec-
ommendations based on the two modalities were rather
consistent [51]. These studies show on the one hand that
compared to a WST, the CSE provides clinically relevant
additional information, particularly regarding the assess-
ment of the oral phase. On the other hand, inherent
weaknesses of the CSE regarding the assessment of
safety and efficacy of swallowing and in particular the
pharyngeal phase have become obvious.
Flexible endoscopic evaluation swallowing (FEES)
Flexible Endoscopic Evaluation Swallowing (FEES) has
been established nowadays in many German acute and
rehabilitation clinics as diagnostic standard for the
evaluation of swallowing. For example, a recent survey
of German Stroke Units shows that the FEES is available
here in more than 70% of the facilities, which corre-
sponds to an increase of approximately 25% in the 5-
year time frame [52, 53]. Consequently, in the meantime
FEES has also been included in the catalogue of struc-
tural criteria for the DSG-Stroke Unit certification [54].
In addition, FEES was mentioned in a recent inter-
national survey (Management of Dysphagia on the ICU,
MADIcu) by more than 80% of neurointensivists as a
regularly applied diagnostics for swallowing evaluation
[55]. In a second survey carried out in the Netherlands
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60% of intensivists reported to have access to FEES [56].
The fact that three major specialist societies (DGN, DSG
and DGG) are now jointly running a training program
to provide a formalized training in this examination
technique, reflects the constantly growing recognition
and importance of FEES [57, 58]. In addition, the DGPP
and DGHNOKHC have created a training curriculum
for the diagnostics and therapy of oropharyngeal dyspha-
gia with FEES as a main subject [59]. During FEES, a
flexible rhinolaryngoscope is inserted transnasally via the
lower or middle nasal meatus into the pharynx. FEES
provides a comprehensive picture of the pharyngeal
phase of swallowing and enables the detection of indirect
signs of impairment within the oral and oesophageal
phases. The aims of FEES are, in particular, to identify
pathological movement patterns, to assess the effective-
ness and safety of swallowing, to determine suitable food
consistencies and feeding strategies and to guide the use
of therapeutic maneuvers for the individual patient. The
standard FEES protocol consists of following steps (i)
anatomical-physiological examination, (ii) swallowing
without and with defined test boli, (iii) review of the ef-
fectiveness of therapeutic methods [60]. Various scales
are available for the evaluation of the salient endoscopic
findings (e.g. penetration aspiration scale according to
Rosenbek [61], the Yale Residue Scale [62], Secretion Se-
verity Scale [63]; Scale for Quantification of premature
spillage [64]. Besides the standard FEES protocol specific
examination protocols have been developed and vali-
dated for various clinical issues (FEES Tensilon-Test and
Fatigable Swallowing Test for the detection and follow-
up evaluation of a myasthenic dysphagia; FEES-L-Dopa-
Test for evaluation of L-Dopa-sensitive dysphagia in pa-
tients with Parkinson's syndrome; FEDSS for the grading
and management of stroke-related dysphagia; Decannu-
lating algorithm to assess the feasibility of decannulation
in tracheotomized intensive care patients [65]). In
addition, structural abnormalities found within FEES, no
matter whether they are pathophysiologically related to
impaired deglutition or not, need to prompt a consult-
ation by an otolaryngologist or phoniatrician. For ex-
ample, redness, swelling and mucosal thickening in the
posterior glottic area can indicate a gastro-oesophago-
pharyngeal reflux, which untreated can lead to severe
pulmonary infections in patients at risk of aspiration.
The FEES registry study analyzed side effects and clin-
ical impact of FEES in everyday clinical practice in a pro-
spective multricenter design [66]. 2401 patients were
recruited in 23 hospitals between 2014 and 2017. The
diagnostic spectrum included all relevant neurological
diseases associated with dysphagia, in particular stroke,
Parkinson's disease, critical illness polyneuropathy,
motor neuron disease, dementia, myasthenia gravis, and
myopathies. The first main result of the study was that
FEES was performed safely regardless of the examiner's
previous experience and was well tolerated by the pa-
tients. Secondly, the study showed in accordance with
Braun et al. that FEES had a significant impact on dys-
phagia management [67]. Based on the results of FEES,
more than 40% of patients were able to obtain a more
liberal oral diet, while more than 10% required a more
cautious nutritional approach. In the subgroup of tra-
cheotomized patients (N=447), based on FEES decannu-
lation was possible in more than 25% of cases. A
retrospective study showed that after the implementa-
tion of bedside FEES service on a stroke unit, a signifi-
cant reduction in pneumonia rates (12% to7%) could be
achieved. In addition, patients were more likely to re-
ceive a regular diet at discharge, while the duration of a
non-oral nutrition and the duration of hospital stay in-
creased under the new regimen [68].
Video fluoroscopic evaluation of swallowing
The Videofluoroscopic Swallowing Study (VFSS), or the
modern digital method (Digital Fluoroscopic Swallowing
Study, DFSS), is a contrast based, radiological examin-
ation of the entire swallowing act including oral,
pharyngeal, and oesophageal stages. VFSS is today usu-
ally performed according to the Logemann standard
[69]. Here, the patient is examined in the lateral view
with liquid boli of increasing volume up to consecutive
cup swallowing. The patient is then given semisolid and
lastly solid test boli. Finally, if required, the patient is ex-
amined in the anterior-posterior view, which is particu-
larly appropriate to detect lateral asymmetries (e.g.,
unilateral residues in the case of a one-sided pharyngeal
palsy). This examination step can be complemented by a
“Valsalva maneuver” to depict hypotonic parts of the
pharyngeal constrictors or, very rarely, pharyngoceles.
VFSS distinguishes between dysphagia symptoms (e.g.
aspiration, residues) and underlying pathomechanisms
[70]. In addition, this technique offers apart from quali-
tative parameters also quantitative measures, such as the
oral onset time, the oral transit time, the pharyngeal
transit time, the anterior-superior movement of the
hyoid, the duration and width of the velopharyngeals
closure and the duration and width of the opening of
the upper oesophagus sphincter. In a large number of
studies on different patient cohorts, it has been shown
that specific VFSS parameters, such as the latency of the
laryngeal closure and the opening of the UES are associ-
ated with penetration and aspiration [71, 72]. In
addition, these and other VFSS findings have been iden-
tified as indicators for the recovery of swallowing func-
tion after stroke [73] or for the responsivity of dysphagia
to swallowing interventions [74]. Besides these specific
parameters global VFSS-based dysphagia scores that
provide a graduation of dysphagia severity have also
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been developed and validated. For example, the "Modi-
fied Barium Swallow Study Impairment Profiles
(MBSimP©™) aggregates 17 single parameters of swal-
lowing physiology to an overall score [75]. The MBSImP
has now been successfully used in basic research [76]
and has been adopted to characterize dysphagia in
COPD patients [77]. The DIGEST (Dynamic Imaging
Grade of Swallowing Toxicity), on the other hand, sum-
marizes parameters of swallowing safety and swallowing
efficiency in a 5-step score [78], which has been
employed in patients with oculopharyngeal muscular
dystrophy and amyotrophic lateral sclerosis [79, 80]. The
PDVFS (Parkinson Disease VFSS Scale) was developed
as a disease-specific score to predict the risk of aspir-
ation pneumonia [81]. Highlighting the concrete benefits
for the dysphagia management a retrospective study
showed that in dysphagic stroke patients VFSS could be
used to safely change the route of feeding from artificial
enteral nutrition via an NG-tube to an oral diet [82]
FEES and VFSS in comparison
Among the instrumental methods VFSS and FEES add
to each other in their significance and regarding their
advantages and disadvantages. Depending on the clinical
scenario, one or the other method can yield the larger
diagnostic gain, so that neither of the two techniques is
considered to be the only gold standard of the dysphagia
diagnostics, but both methods are considered comple-
mentary. Methodologically, VFSS offers the advantage
that the entire swallowing act, including the oral phase,
pharyngeal constriction, epiglottic inversion, hyolaryn-
geal elevation, upper oesophageal sphincter function and
the oesophageal phase is captured in high time reso-
lution. Based on VFSS it is possible to detect and to
comprehensively describe complex pathomechanisms of
swallowing disorders affecting laryngo-pharyngeal and
-oesophageal interactions. Apart from radiation expos-
ure disadvantages of VFSS are the need for patient trans-
port and the relatively high demands on the patient's
ability to cooperate. FEES on the other hand, is meth-
odologically restricted by the fact that it is focused on
the pharyngeal phase of swallowing and is affected by
the so-called white-out phenomenon. The practical
merits of FEES in everyday routine are that it can be
performed at the bedside, thus facilitating examination
of severely motor-impaired, bedridden or uncooperative
patients, that follow-up examinations can be performed
at short notice and, if necessary, frequently; and that
oropharyngeal secretion management and efficacy of
cleaning mechanisms, such as coughing and throat clear-
ing, can be assessed simply and directly. During recent
years, several studies have shown that VFSS and FEES
are comparable regarding the detection of swallow-
specific main findings. Thus, a meta-analysis of 6 studies
concluded that FEES detected penetrations/aspirations
as well as residues somewhat more sensitively than VFSS
while premature spillage has been diagnosed equally well
by both methods [83]. In newer studies performing VFSS
and FEES simultaneously in smaller patient cohorts,
there was also a moderate superiority of FEES for the
detection of residues, while the results were not consist-
ent in terms of penetration and aspiration, but in the
majority of patients both methods matched reasonably
well [84, 85]. So far, only one prospective study recruit-
ing a heterogeneous cohort of dysphagic outpatients (n=
126) investigated whether dysphagia management rec-
ommendations based on FEES or VFSS resulted in better
outcomes [86]. The patients were followed up for one
year after initial instrumental evaluation. There were no
significant differences in terms of pneumonia incidence
and pneumonia free interval between the two diagnostic
modalities. Only in the subgroup of chronic stroke pa-
tients (n=45) pneumonia rate was higher in patients
managed with VFSS (29%) than with FEES (5%).
Manometry
Manometry, in particular high-resolution manometry
(HRM), allows the endoluminal pressure conditions in
the pharynx and oesophagus to be measured during the
swallowing act. The method is particularly suitable to
prove relaxation disorders of the UES and motility disor-
ders of the oesophagus (achalasia, diffuse oesophagos-
pasm). Oesophageal manometry can be carried out with
standard tubes for which standard values have been
established [87]. In particular, the following parameters
can be assessed: resting pressure, opening of the upper
and lower oesophageal sphincters as well as peristalsis,
pressure and amplitudes of the tubular oesophagus. For
gastroenterological disorders of the oesophagus, an as-
sessment based on the Chicago Classification is common
[88]. Only in recent years, HRM was used for the assess-
ment of the oesophageal motility in patients with neuro-
logical diseases, especially Parkinson syndromes [89],
inflammatory myopathies [90] and Morbus Huntington
[91]. In neurology HRM is particularly important in pa-
tients with opening disorders of the UES, e.g., as a result
of myopathies or strategic brainstem infarctions. Here,
HRM is instrumental for the indication of interventions
at the UES (myotomy, dilatation, botulinum toxin injec-
tion) and post-interventional follow-up [92]. In contrast
to oesophageal manometry, for the less common
pharyngeal HRM there are still no standard values, since
location and diameter of catheters used vary signifi-
cantly. In addition to the resting tonus of the UES, peak
pressures and contraction times of the velopharynx and
base of tongue, total swallowing time, speed of
pharyngeal contraction wave as well as the length of the
active pharyngeal segment can be determined [93].
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Recently, pharyngeal HRM has been used in various
neurological diseases, such as stroke [94], Parkinson's
disease [95] and inflammatory and genetically deter-
mined myopathies [96] to describe the pattern of swal-
lowing impairment. In addition, HRM has been
compared with other methods of instrumental evalu-
ation of swallowing, in particular VFSS and FEES and
has been identified as a prognostic indicator. Despite its
potential to complement FEES and VFSS, pharyngeal
manometry has still not been successfully integrated into
routine dysphagia diagnostics. A recent survey involving
206 speech therapists from the US revealed that only
3.5% of them have access to HRM, and only half of this
small group actually uses pharyngeal manometry for fur-
ther diagnostics in patients with dysfunctions of the
upper oesophageal sphincter [97].
Further modalities of instrumental evaluation of swallowing
With electromyography (EMG) the activation pattern of
the majority of muscles involved in the swallowing act
can be analyzed. Depending on the target muscle surface
or needle electrodes need to be used [98]. In the litera-
ture the examination of four specific muscle groups with
surface electrodes is recommended: M. orbicularis ori
and M. masseter for the oral phase, the suprahyoidal or
submental muscles (M. digastricus, M. mylohyoideus, M.
geniohyoideus) and the infrahyoidal muscles (M. thyro-
hyoideus, M. sternothyroideus) for the pharyngeal phase.
Needle electrodes can also be used to record the activa-
tion of the cricopharyngeal muscle as part of the upper
oesophageal sphincter [99]. In the clinical routine, EMG
is primarily used within swallowing therapy as biofeed-
back for enhancing the training of compensatory swal-
lowing maneuvers. Here, muscle activity is recorded via
submentally positioned EMG surface electrodes and can
be presented graphically or audible to the patient [100].
With sonography dynamics of the oral swallow and
the morphometry of oropharyngeal muscles can be stud-
ied. With a suitably positioned sector transducer, oral
bolus transport, tongue motor activity, suprahyoidal as
well as hyoidal and laryngeal movements can be visual-
ized in real time. Even details of the intrinsic tongue
muscles can be anatomically differentiated with modern
ultrasound probes [97].
Dynamic magnetic resonance imaging (MRI), in par-
ticular adopting “Turbo Fast Low Angle Shot (turbo-
FLASH) Sequences” at higher field strengths (≥ 3 Tesla),
provides a series of anatomical images in rapidly ac-
quired consecutive slices [101]. The dynamic MRI of the
swallowing act is a non-invasive procedure without ex-
posure to radiation with a relatively short examination
time in a range of a few minutes and, therefore, theoret-
ically also applicable to children. It also allows a direct
view on the deeper oropharyngeal muscles and soft
tissue, multiplanar and in motion, and (depending on
the section plane) provides a simultaneous view of the
oral cavity, pharynx, and larynx and a tracking of the
bolus transit during the swallowing act. The time reso-
lution now approaches that of VFSS at around 25 im-
ages/s. Comparative studies with either VFSS or FEES
showed a good agreement of the dynamic MRI with
these two established gold standard methods [102]. The
main limitations of this technique in the context of dys-
phagia diagnostics are, on the one hand, the flat posi-
tioning in MRI that is usually non-physiological for
swallowing and may exacerbate the swallowing impair-
ment and, on the other hand, the limited ability to inter-
vene due to the little space in the scanner, particularly
when examining patients at risk of aspiration.
For computed tomography scanning, further technical
developments such as the 320-row multi-slice CT offer
potential applications for swallowing diagnostics. Due to
the thin slice thickness and the high temporal resolution
of the acquired images, four-dimensional data sets can
be reconstructed in good temporal and spatial reso-
lution. Inamoto and colleagues were able to perform a
CT-based kinematic analysis of the swallowing act from
the oral to the early oesophageal phase for the first time
by using a scanner that enables the examination in a
half-sitting position [103]. In initial studies, this tech-
nique was used to optimize the quantification of
pharyngeal residues [104], to describe age-dependent
changes in swallowing physiology [105] and to assess the
influence of bolus volume [106], bolus viscosity [107]
and swallowing maneuvers on the swallowing act [108].
The differential indications of the described instru-
mental procedures are summarized in Table 1.
Algorithm for a structured assessment of patients with
neurogenic dysphagia
The questions targeted by comprehensive dysphagia
diagnostics depend on the specific clinical context. Ba-
sically, two scenarios can be differentiated here: dyspha-
gia with an already determined etiology and dysphagia of
unclear etiology.
Dysphagia with determined etiology If patients with
an etiologically classified, known dysphagia are exam-
ined, dysphagia diagnostics pursue the goal of determin-
ing the optimal dysphagia management for the patient in
addition to the treatment of the underlying disease. The
most important task in this context usually is to deter-
mine the safest and most convenient form of nutrition.
In addition, it should be tested in particular whether the
use of specific techniques (e.g., chin-tuck maneuvers,
Mendelsohn maneuvers) can improve the swallowing
function. In view of the above-described immanent
methodological advantages, and because of the
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increasing availability, safety and diagnostic yield, FEES
should be carried out as the first instrumental method
to clarify these questions [109]. The FEES registry study
showed that in a heterogeneous, neurological patient co-
hort, the patients’ diet needed to be adjusted based on
the FEES results in more than 50% of the patients [66].
In a second study, FEES required a change of feeding
strategy in two thirds of the patients [67]. In a third
study recruiting a cohort of Parkinson patients, 18% of
patients without subjective swallowing impairment re-
quired compensatory techniques and regular swallowing
therapy due to the objective severity of their dysphagia
determined by FEES. In 8% of the same subgroup, the
swallowing disorder was so severe that tube feeding was
required [4]. The key parameters helping to determine
safety and efficacy of swallowing are the consistency-
specific assessment of penetration and aspiration on the
one hand and residues on the other [109]. Established
scores such as the penetration-aspiration scale [61, 110]
and the Yale residue scale [62, 111], both of which have
been validated in German, should be used for a more
precise and easy-to-communicate rating.
If there are questions beyond the definition of nutri-
tional management that cannot be answered adequately
with FEES alone (e.g. extent UES dysfunction, additional
presence of oesophageal dysphagia), further instrumental
procedures, in particular the VFSS and HRM, should be
used.
Etiologically undetermined dysphagia Basically, the
work-up in case of an etiologically unexplained dyspha-
gia requires interdisciplinary diagnostics, which, depend-
ing on the clinical situation, should involve
gastroenterologists, neurologists, otolaryngologists, pho-
niatricians, SLPs, geriatricians and radiologists. To differ-
entiate between structural and neurogenic dysphagia, an
appropriately qualified examination of the oropharynx
and a pharyngolaryngoscopy are required. Further
gastroenterological diagnostics using oesophagogastro-
scopy and manometry (see above) is indicated if there is
a suspicion of oesophageal dysphagia. In order to initiate
proper protective and rehabilitative measures, it is essen-
tial to diagnose the underlying dysphagia-causing dis-
ease. In addition, relevant statements regarding the
prognosis can only be provided to patients and relatives
if the etiology of neurogenic dysphagia has been clarified
[65]. As shown in Fig. 1, the diagnostic procedure differs
depending on whether a neurological disease is already
known or not.
If no neurological diagnosis has previously been estab-
lished, the further procedure depends on the presence of
anamnestic or additional clinical symptoms that give rise
to specific diagnostics (see Table 2). If, for example, the
clinical neurological examination reveals cranial nerve
paresis a cranial polyneuritis or a basal meningitis need
to be considered. If a diagnosis can be made on the basis
of this clinical information and the further examinations,
a specific therapy can be initiated thereafter.
Instrumental diagnostics are used here primarily to
plan dysphagia management and to evaluate the success
of the targeted treatment (see above). However, if dys-
phagia is the sole or predominant symptom of a neuro-
logical disorder, differential diagnosis is often more
difficult. In these cases, after a medical history and
neurological examination, FEES should be carried out.
In contrast to the situation outlined above, where the
main aim of swallowing assessment was to propose a
suitable dysphagia management strategy, in this scenario
it is essential to carefully determine the phenotype of the
swallowing impairment (Table 3) [65]. If there are spe-
cific or at least suggestive findings (e.g., disorder of the
UES, fatigue of the swallowing muscles during the exam-
ination), the subsequent diagnostics should be focused
on FEES-based differential diagnosis. In the case of an
unspecific phenotype of swallowing impairment and de-
pending on the clinical constellation, a contrast-




Endoscopy (FEES) gold standard; particularly suitable for assessment of saliva accumulation and for sensory testing, preferred
method in stroke units and neurological intensive care units
Videofluoroscopy (VFSS) gold standard; evaluation of all swallowing phases; particularly suitable for assessing intra-deglutitive aspir-
ation, hyolaryngeal elevation, epiglottic tilt, contact of the tongue-base to the back of the pharyngeal wall
and impaired opening of the upper oesophageal sphincter
Manometry Recording of timing and amplitude of the pharyngeal and oesophageal contraction and impaired opening of
upper and lower oesophageal sphincter (in particular important before possible cricopharyngeal myotomy),
oesophageal motility disorders
Electromyography (EMG) biofeedback, otherwise mainly experimental procedure
Sonography currently mainly experimental procedure
Magnetic resonance imaging (MRI) currently mainly experimental procedure
Computer tomography (CT) currently mainly experimental procedure
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enhanced MRI of the brain with thin sections of the
brain stem, neurophysiological examinations, a FEES
tensilon test, the determination of auto-antibody pro-
files, a lumbar puncture and / or a whole-body Muscle
MRI should be considered next [65].
Evaluation of pill swallowing
Taking oral medication, especially swallowing tablets, is
a relevant problem for many patients with dysphagia. In
addition to aspiration and the resulting complications
and discontinuation of medication, unsuitable modifica-
tion of the oral medication can often be observed (e.g.,
crushing, breaking, and opening of tablets and capsules),
which may lead to numerous problems, such as de-
creased accuracy of dose, increased toxicity, reduced sta-
bility, and alteration of pharmacokinetics [112].
Therefore, especially in patients with dysphagia who are
required to take oral medication, swallowing of tablets
should be routinely evaluated as part of the swallowing
assessment and the optimal formulation (if available)
should be identified [20]. In a study recruiting Parkinson
patients, almost 30% of them as well as about 15% of the
control subjects showed impaired pharyngeal transfer of
the placebo tablets [7]. A proof-of-principle study in an
etiologically heterogeneous group of dysphagic patients
(N = 36) also showed that an orodispersible tablet was
easier to swallow than a conventional tablet of the same
size [113].
Dysphagia assessment in patients with a nasogastric tube
In patients with severe neurogenic dysphagia, nasogastric
tube feeding is often recommended, at least temporarily,
to ensure safe and sufficient enteral feeding [26]. Despite
contrary recommendations in other guidelines [114],
from a practical point of view it is important to consider
that a nasogastric tube should not be removed for in-
strumental or clinical dysphagia diagnosis or for dyspha-
gia therapy. In several studies, each with a different
design and patient cohort, no clinically relevant negative
effects of the tube on the swallowing function and aspir-
ation risk, both determined by FEES or VFSS, could be
identified [115, 116]. However, it must be taken into ac-
count that a nasogastric tube can cause swelling of the
arytenoids as well as lesions to the pharyngeal mucosa,
which in turn may cause difficulty swallowing and may
be an indication for the PEG placement.
Dysphagia assessment in tracheotomized patients
Tracheotomy, particularly the minimally invasive dilata-
tion procedure, has become a standard procedure in
most intensive care units, so that today the majority of
long-term ventilated patients are ventilated via this air-
way access. After successful weaning from the respirator,
the next therapeutic goal is to remove the tracheal can-
nula. In view of the high prevalence of swallowing disor-
ders in tracheotomized patients, dysphagia assessment
plays a major role in tracheal cannula management
Fig. 1 Structured algorithm for the diagnosis of neurogenic dysphagia [65]
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Table 2 Differential diagnosis of neurogenic dysphagia in relation to additional neurological symptoms (according to [65])
Additional neurological symptoms Differential diagnoses
Acute CNS symptoms cerebral infarctions/bleeding
relapse of multiple sclerosis
Slowly progressive CNS symptoms brain tumors
chronic progressive multiple sclerosis














Progressive bulbar paralysis Amyotrophic lateral sclerosis
Pseudobulbar paralysis
Primary lateral sclerosis




Cerebellar symptoms Multiple sclerosis
Hereditary ataxias
Niemann–Pick disease, type C
Subacute cerebellar degeneration
Cranial nerve palsies Skull base tumors
Meningeosis neoplastica
Basal meningitis
Subtypes of Guillain–Barré syndrome
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[117]. In principle, the following three methods are
available.
1. The clinical swallow examination is usually carried
out as the first diagnostic step in cannulated
patients weaned from the respirator. After deflating
the cannula’s cuff and careful subglottic suctioning
a physiological air flow through the upper airway is
achieved by capping the cannula or using a
speaking valve. This is followed by the swallowing
examination, which is based on the usual
procedure, and in particular searches for clinical
signs of penetration and aspiration of saliva and
administered food boluses. In accordance with
the low reliability of the clinical swallow
examination for detecting these critical events the
sensitivity of this method in comparison to gold
standard FEES is low. Therefore, weaning a
patient from the tracheal cannula cannot be
controlled only based on the clinical swallow
examination [118].
2. As a further clinical instrument, the Evans Blue
Test (EBT) and the modified Evans Blue Test
(mEBT, Evans blue dye test) have been introduced
into practice [119]. To carry out the test, the
cannula’s cuff is first deflated and subglottic and
pharyngeal secretion is carefully suctioned. The
patient then receives a few drops of food coloring
directly on the tongue or the patient is given orally
small amounts of food-color dyed liquid (EBT) and
possibly other food consistencies (mEBT). After the
swallow, subglottic suctioning is repeated. If colored
secretion (EBT) or colored liquid (mEBT) are de-
tected, a high risk of aspiration is suspected. Ac-
cording to several studies and a meta-analysis this
method features an insufficient sensitivity [120],
while only two studies with repeated suction tests
suggest an acceptable accuracy of the (m) EBT
[121, 122]. In summary, a negative (m) EBT is of no
diagnostic value, but a positive (m) EBT is consid-
ered to be indicative of substantial risk of aspiration
in tracheotomized patients. In view of this scientific
Table 2 Differential diagnosis of neurogenic dysphagia in relation to additional neurological symptoms (according to [65])
(Continued)






Myotonic syndrome Myotonic dystrophies
Trismus and/or risus sardonicus Tetanus
Table 3 Endoscopic phenotypes of neurogenic dysphagia [65]
Main findings Neurological diseases
Peripheral Central
I) Premature spillage Early-stage ALS Early-stage ALS, early-stage PSP, fronto-
temporal dementia, SPG7-HSP, acute
stroke*
II) Delayed swallow reflex Acute stroke*
III) Impaired pharyngeal bolus clearance (residue in
valleculae >>> residue in piriform sinus)
Bulbospinal muscular atrophy, myotonic dystrophy
type II, (critical illness neuropathy/myopathy,) early
stage ALS
Early ALS, early-stage PD
IV) Impaired opening of upper oesophageal
sphincter (residue in piriform sinus >>> residue in
valleculae)
Inclusion body myositis (IBM) Dorsolateral medulla oblongata
infarction
V) Complex pathology (combination of I-IV, at least
2 equivalent patterns)
Severe myasthenia gravis, end-stage ALS, (GBS), myo-
tonic dystrophy type I
End-stage ALS, advanced stages of PD
and PSP
VI) Extrapyramidal motor impairment (one out of I-
IV) plus movement disorder
– Neuroleptic-induced dysphagia, PD,
MSA, Huntington’s disease
VII) Fatigable oropharyngeal dysphagia (one out of
I-IV plus swallowing fatigability)
Myasthenia gravis (PD, ALS)
*All stroke locations apart from strokes confined to the dorsolateral medulla oblongata
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context, the (m) EBT should be classified as a
screening instrument that can be used to follow-up
instrumental evaluation. The exclusive use of the
(m) EBT to assess readiness for decannulation is
not recommended.
3. Due to the limitations of the clinical procedures
described above, FEES is also of relevance this
context. Hafner and co-workers have already shown
that based on FEES, almost 23% of 258 tracheoto-
mized patients could be decannulated [123]. A com-
parable rate was also reported in the FEES registry
study, where removal of the tracheal cannula was
possible in 26.4% of the 447 tracheotomized pa-
tients [66]. In addition, Cohen et al. showed that
decannulation immediately following the endo-
scopic evaluation was associated with fewer recan-
nulations, a shorter period of non-assisted
spontaneous breathing before decannulation, and a
shorter hospital stay after decannulation than a
more protracted decannulation management [124].
In order to increase the reliability of the endoscopic
examination, a standardized procedure that focuses
on the parameters management of secretions, spon-
taneous swallowing rate and laryngeal sensitivity
has been developed [125]. The application of this al-
gorithm in 100 tracheotomized intensive care pa-
tients weaned from the respirator allowed for a
rapid and safe decannulation in more than half of
this patient cohort; only in one case recannulation
was necessary in the further course of treatment. It
was also noteworthy that the clinical swallowing
examination, which took into account the parame-
ters vigilance, ability to cooperate, saliva swallowing,
coughing as well as the amount of secretions suc-
tioned from the tracheal cannula, would have rec-
ommended removal of the tracheal cannula in only
half of these patients [125]. In the meantime, this
decannulation algorithm has been successfully used
as primary endpoint of a multicenter study [126] and
was also recommended by a French guideline [127].
Further recommendations for tracheostomy tube
management
Tracheotomized patients are usually treated by a multi-
professional team that, depending on the local condi-
tions, is composed of intensive care physicians,
otolaryngologists, phoniatricians, respiratory therapists,
SLPs and specialized nursing staff [128]. Even if no pro-
spective randomized trials have been done so far and
recommendations therefore have only a weak evidence
base [129], a large number of studies with different de-
signs and also individual meta-analyzes suggest that this
interdisciplinary approach improves the prerequisites for
rapid and safe decannulation [128, 130, 131]. Frank and
co-workers. demonstrated in a study with pre-post de-
sign that after the implementation of a multi-
professional tracheal cannula management consistently
high decannulation rates and a > 50% reduction of aver-
age cannulation times were achieved [130]. These results
were confirmed in a meta-analysis of 7 other cohort
studies with a comparable design [128], which, in
addition to accelerated weaning from the tracheal can-
nula, also described a shortening of the length of stay on
the intensive care unit and a reduction of complications
subsequent to the implementation of multiprofessional
teams. In addition to the swallowing function and oro-
pharyngeal secretion management (see above), the dedi-
cated decannulation assessment also evaluates the
patient's alertness and ability to cooperate, the respira-
tory function and anatomy of the airway, the voluntary
and reflectory cough as well as the amount, consistency
and clearing of the bronchial secretion [132, 133]. Also,
the position, fit and patency of the cannula, the presence
of granulation tissue, and the position of the cannula’s
fenestration, if any, should be checked by regular endos-
copy [132]. Especially if gradual weaning from the tra-
cheal cannula is required, recurrent and progressively
longer trials of cuff deflation with simultaneous capping
of the tracheal cannula or use of a speaking valve are
used during the rehabilitation [132, 134]. On the one
hand, this procedure helps patients to practice breathing
through the upper airway. On the other hand, the restor-
ation of the physiological air flow is likely to result in a
restitution of the pharyngeal and laryngeal sensitivity
with consecutively improved secretion management
[135]. In a proof-of-principle study recruiting 20 tra-
cheotomized stroke patients, Ledl and Ullrich showed
that while capping of the tracheal cannula did not in-
duce any changes in swallowing mechanics, swallowing
safety improved resulting in lower Penetration-
Aspiration-Scale scores [136]. Regular, temporary
decannulation as part of swallowing diagnostics or
therapy does not appear to have any advantage over
temporary capping of the cannula. In methodically
high-quality studies, there was no change in different
parameters of swallowing mechanics and swallowing
safety between the conditions “swallowing with
unblocked and capped tracheal cannula” and “swal-
lowing without tracheal cannula” [137, 138]. As an
important intermediate step before starting longer pe-
riods of cuff deflation with capping or use of a speak-
ing valve, downsizing the cannula’s inner diameter is
frequently necessary to reduce airway resistance [139].
Definitive decannulation is usually possible if manage-
ment of pharyngeal secretions is sufficient and pa-
tients stay respiratory stable and tolerate 24 to 48
hour periods of cuff deflation combined with capping
without complications [132, 134].
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Therapy
A variety of different therapeutic methods are now avail-
able for the treatment of neurogenic dysphagia. Since
the indication for a specific treatment is determined not
only by the phenotype of swallowing impairment, but
also by the underlying etiology of dysphagia, an appro-
priately focused diagnostic work-up (see above) is essen-
tial before the final therapeutic strategy is determined.
In this section, dietary, behavioral, pharmacological, and
local interventional treatment options as well as neuro-
stimulation procedures are presented and the import-
ance of oral hygiene in patients with dysphagia is
explained.
Dietary interventions
Recommendation 29: Texture-modified diets, thick-
ened liquids and / or systematic modifications of
bolus size should only be prescribed based on the
findings of a swallow examination.
Recommendation 30: Thickening of liquids can be
used in patients with neurogenic dysphagia who show
aspirations with liquids.
Recommendation 31: To improve patient compli-
ance, different types of thickeners should be offered
and tested.
Recommendation 32: Texture-modified diet can be
used in patients with chronic dysphagia to improve
their nutritional status.
Recommendation 33: Despite the use of texture-
modified food and thickened liquids, patients with
neurogenic dysphagia are at increased risk of malnu-
trition, dehydration, and aspiration pneumonia and
should, therefore, be monitored for these
complications.
The use of texture-modified foods and thickened liq-
uids has become one of the most common therapeutic
strategies to address neurogenic dysphagia. The idea be-
hind this approach arises from the assumption that
modifying the properties of normal food and liquids will
make them easier and safer to swallow [140]. Despite
the widespread use of this intervention, its scientific
foundation in many areas is still incomplete or not
convincing.
For decades there were no established and universally
used terminology and definitions to describe the target
consistency recommended for patients with OD and to
guide its preparation [140]. Only recently the “Inter-
national Dysphagia Diet Standardisation Initiative”
(IDDSI) has been established that pursues the goal to
develop global standardized terminology and definitions
for texture modified food and thickened liquids for individ-
uals of all ages, in all care settings, and all cultures [141].
Despite this ongoing discussion focused on termin-
ology and definition issues [142], the effect of liquid
thickening on the safety and efficacy of the swallow has
been extensively investigated [143]. The results of more
than 30 studies were summarized and analyzed in two
recent systematic reviews and a white paper [140, 144,
145]. Those papers unanimously conclude that thicken-
ing liquids reduces the risk of aspiration in different pa-
tient groups. Although the available data are insufficient
to suggest particular viscosity values, the analysis put
forward by Newman and colleagues suggest that on the
continuum covering the whole spectrum from “thin”,
“nectar”, “honey” to “spoon thick”, there seems to be a
dose-response characteristic with thicker liquids being
safer than thinner liquids [145]. As a flip side of the coin,
liquid thickening seems to increase the risk of post-
swallow residues [140, 144, 145]. Although not as un-
equivocal and as frequently studied as aspiration, several
studies reported oral and/or pharyngeal residues with
ultra-thick liquids [37, 72, 146, 147].
As an alternative or supplement to viscosity adapta-
tion, the bolus volume can also be adjusted. As shown in
a systematic review, bolus volumes ≤ 5 ml have a lower
aspiration risk than bolus volumes ≥ 10 ml [148].
In addition to these effects focused on the physiology
of swallowing, clinically relevant endpoints have also
been studied in the context of liquid thickening and tex-
ture modifications. Contrasting with its positive effect on
swallowing safety, liquid thickening has failed to substan-
tially improve fluid intake in several studies [149, 150] and
systematic reviews [151, 152]. The main reason for this is
that thickened liquids are poorly tolerated due to changes
in taste, a “coating feeling in the mouth” and an insufficient
alleviation of thirst [153]. In addition to a compliance-
related, reduced fluid intake, thickening of liquids, there-
fore, correlated with a reduced quality of life [154].
Apart from viscosity, thickening agents also influ-
ence other characteristics of the liquids, such as
texture, taste, and appearance. There is first evi-
dence that different types of thickeners, in particu-
lar starch and rubber-based products, differ in this
respect, which can have an impact on patient com-
pliance [147].
The impact of feeding strategies involving texture
modified diets on oral intake has been assessed in one
small RCT [155]. In elderly dysphagic nursing home res-
idents both food intake and nutritional status were im-
proved in the intervention group over a time period of
12 weeks. In addition, a cohort study recruiting acute
stroke patients showed that by being given a dysphagia
diet, patients could achieve more than 75% of their en-
ergy requirements [156].
The effect of dietary interventions to prevent aspir-
ation pneumonia has been studied in several systematic
reviews and Cochrane analyses related to patients with
dementia [157, 158], geriatric stroke patients [159] and
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geriatric patients with oropharyngeal dysphagia of het-
erogeneous etiologies [151]. It is generally concluded
that the number of high-quality studies is too low to rec-
ommend the use of texture modified food and thickened
liquids for the prevention of aspiration pneumonia. Of
particular relevance in this context is the large RCT by
Robbins and co-workers, which included more than 500
patients with dysphagia due to Parkinson’s disease or de-
mentia and proven aspiration of thin liquids in VFSS.
This study did not find a significant difference in the in-
cidence of aspiration pneumonia between the group re-
ceiving thickened liquids and the group being treated
with chin-down posture and normal liquids [160].
While dietary interventions in isolation appear to have
only a small effect size, this approach may be more ef-
fective and meaningful when used within a multidimen-
sional concept to prevent aspiration pneumonia. Thus,
the so-called „Minimal-Massive Intervention (MMI)",
which aims to reach as many patients as possible with a
resource-saving (minimal) intervention and thereby
achieve a large ("massive") effect, comprises the compo-
nents (i) fluid and food texture adaptation, (ii) dedicated
oral care (see below) and (iii) nutritional supplementa-
tion and targets the group of frail geriatric patients [161]
In a prospective non-controlled intervention study,
this set of measures was used to reduce mortality, pneu-
monia rates and the rate of re-hospitalization and to im-
prove the nutritional status of patients compared to a
historical control group [161].
Behavioral swallowing interventions
Recommendation 34: Before initiating behavioral
swallowing interventions, the etiology and phenotype
of dysphagia should be determined.
Recommendation 35: The Shaker maneuver should
be used in patients with pharyngeal residues and im-
paired opening of the UES.
Recommendation 36: Expiratory muscle strength
training (EMST) should be used to treat dysphagia in
patients with motor neuron disease, stroke and M.
Parkinson. EMST should preferentially be applied
within prospective clinical trials.
Recommendation 37: The chin-tuck maneuver
should be used to improve swallowing safety in pa-
tients with impaired oral bolus control and consecu-
tive premature spillage with subsequent
predeglutitive aspiration.
Recommendation 38: Effortful swallowing can be
used to improve tongue strength and swallowing
physiology.
Recommendation 39: A systematic, regular and in-
dividualized behavioral swallowing therapy should be
used early on in patients with neurogenic dysphagia,
especially in patients with post-stroke dysphagia.
Exercises and maneuvers probably constitute the most
widespread treatment approach for patients with neuro-
genic dysphagia. In German-speaking countries, non-
swallow specific concepts such as Kay Coombes’ Facial-
Oral Tract Therapy (F.O.T.T.®) and Castillo Morales’
orofacial regulation therapy (ORT) are as well used as
the so-called functional dysphagia therapy (FDT), which
was significantly developed and put into practice by
Gudrun Bartolome. The latter approach selects interven-
tions according to the concrete pattern of neurogenic
dysphagia that is present in a given patient [162, 163].
Most studies in this scientific area are devoted to the
FDT or single elements of it.
Restorative techniques are intended to restore im-
paired swallowing functions or to promote residual func-
tions. This is done via pre-swallow stimulation (e.g.,
thermal stimuli), mobilization techniques (e.g., tongue
pressing against resistance), and specific motor exercises
(e.g., Shaker exercise, Masako maneuver, EMST).
In contrast, compensatory methods are used during
the swallow to enable effective and safe deglutition des-
pite functional impairments. A distinction is made be-
tween postural maneuvers (e.g., chin-tuck or head-turn
maneuvers) and special swallowing techniques (e.g.
Mendelsohn maneuvers, supraglottic swallowing). Des-
pite their great importance for the treatment of dyspha-
gia in everyday care, the scientific evidence for the
efficacy of this type of treatment is heterogeneous with a
general lack of large RCTs providing clinical meaningful
endpoints [164].
The Shaker head lift is one of the best studied exer-
cises used in dysphagia rehabilitation for many years and
is designed for patients with weakness of the suprahyoid
muscles and impaired opening of the upper oesophageal
sphincter [162, 163]. This procedure is a head rising exer-
cise with an isometric high-intensity portion with three
head lifts held for 60 s with a 60 s rest period between
each one and an isokinetic low-intensity portion that in-
cluded 30 consecutive head lifts of constant velocity with-
out holding. The Shaker head lift has been evaluated in
systematic reviews [165] and several RCT [166–169]
showing that this treatment improves strengths and en-
durance of the suprahyoid muscles and upper oesophageal
sphincter opening. In addition, there is evidence that resi-
dues and aspiration events are reduced.
The tongue muscles can also be trained through tar-
geted exercises. Basically, tongue strength decreases with
age [170], and reduced tongue strength proved to be a
risk factor for aspiration [171]. Tongue strength training
has been evaluated in several cohort studies and one
RCT for the treatment of neurogenic dysphagia.
These trials report different improvements of swal-
lowing variables like vallecular residues and swallow-
ing safety [172, 173].
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The Masako maneuver involves swallowing while pro-
truding the tongue beyond the lips, holding it between
one’s teeth. It is meant to have a strengthening effect on
the tongue and the pharyngeal walls after a period of
training [162, 163]. Studies in healthy subjects did not
find immediate effects on swallowing physiology [174].
A RCT including healthy subjects exposed to a four-
week training with the Masako maneuver or a control
task found no effect on the swallow [175]. In a small
RCT recruiting subacute stroke patients the Masako
maneuver was compared with neuromuscular electrical
stimulation. In that trial both groups showed improve-
ment of swallowing function, however, since a control
group was missing, these results need further confirm-
ation [176].
The so-called Lee Silverman Voice Treatment (LSVT-
LOUD®) was originally developed to treat Parkinson-
related dysphonia. In two smaller observational studies
on 8 respectively 20 Parkinson patients, the authors also
found improvements in various parameters of the oral
and pharyngeal phase evaluated by VFSS [177, 178].
Expiratory muscle strength training (EMST) involves
exhaling quickly and forcefully into a mouthpiece at-
tached to a one-way valve, blocking the flow of the air
until the patient produces sufficient expiratory pressure.
It is meant to strengthen the expiratory and submental
muscles by increasing the physiologic load [164]. This
treatment has shown significant effects on swallowing
safety in a RCT in Parkinson patients [179], has im-
proved swallowing safety and feeding status in an RCT
in subacute stroke patients [180, 181], has been associ-
ated with positive effect on swallowing-related muscle
strength in elderly participants [182], and improved
swallowing safety in patients with multiple sclerosis
[183]. In ALS patients, an RCT and a cohort-study
with pre-post design found that EMST improved
swallow kinematics, in particular hyo-laryngeal eleva-
tion [80]. In patients with Huntington's disease, on
the other hand, no effect of EMST was found on
various parameters of swallowing physiology and clin-
ical endpoints [184]. A meta-analysis summarizing
this evidence across different disease categories also
came to a positive conclusion [185].
The chin-down is a technique used for patients who
have decreased airway protection associated with delayed
swallow initiation and/or reduced tongue base retrac-
tion. To perform this maneuver, patients lower the chin
towards the chest and keep this position during swallow-
ing [162, 163]. In several studies physiological changes
like expansion of the vallecular recesses, approxima-
tion of the tongue base toward the pharyngeal wall,
narrowing of the entrance to the laryngeal vestibule,
expedited onset of laryngeal vestibule closure, reduc-
tion in distance between hyoid and larynx, and
increased duration of swallowing apnea [186]. In two
well-designed cohort studies the aspiration risk could
be reduced by 50% [187, 188].
In patients with unilateral pharyngeal palsy, a head
turn towards the paretic side may be applied, which,
if the respective swallowing impairment also affects
the oral swallowing muscles, may be supplemented by
a head tilt to the non-affected side [162, 163]. These
maneuvers allow swallowing over the non-affected
side and thus lead to a more effective pharyngeal
bolus transfer [189].
The effortful swallow is mainly used in patients with
an inefficient swallowing act characterized by residues in
the valleculae or the sinus piriformes [162, 163]. A var-
iety of effects on swallowing physiology could be attrib-
uted to this maneuver in studies involving both, healthy
subjects and patients with neurogenic dysphagia. Thus,
the effortful swallow has been shown to increase hyolar-
yngeal excursion, duration of hyoid elevation and UES
opening, laryngeal closure, lingual pressures, peristaltic
amplitudes in the distal oesophagus and pressure and
duration of tongue base retraction in healthy subjects
[190, 191]. In an RCT in which healthy subjects were
treated with either effortful swallowing or a sham exer-
cise, a non-significant increase in tongue strength was
found in the treatment group after 4 weeks of interven-
tion [192]. In a small RCT, in which dysphagic stroke
patients either used effortful swallowing or performed a
sham exercise (saliva swallowing), the intervention was
associated with a significant improvement in tongue
strength and oral swallowing function [193]. In addition,
a small cohort study of Parkinson patients showed an in-
crease in manometric pharyngeal pressure levels [194].
The Mendelsohn maneuver is a technique used for pa-
tients with decreased hyolaryngeal excursion and/or de-
creased duration of UES opening and is frequently
combined with some form of biofeedback to help the pa-
tient perform it. To execute this maneuver, patients are
instructed to keep the thyoid cartilage for several sec-
onds in an elevated position before finishing the swallow
[162, 163]. Studies with healthy subjects, have demon-
strated with different methods of instrumental assess-
ment that the Mendelsohn maneuver leads to various
changes in the swallowing process. In particular a pro-
longed contraction of the submental and pharyngeal
muscles, as well as the hyolaryngeal elevators have been
witnessed [195]. According to a recent review, the effect
on hyolaryngeal elevation can be improved by simultan-
eous EMG biofeedback [100]. In a small observational
study, the combined use of effortful swallowing and the
Mendelsohn maneuver in 3 dysphagic stroke patients re-
duced the aspiration risk. Long-term effects of the Men-
delsohn maneuver have been evaluated in one RCT in
stroke patients [196, 197]. In that study the authors
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could demonstrate that hyoid movement and upper
oesophageal sphincter opening improved after
treatment.
The super-supraglottic swallow is used as compensa-
tory maneuver for patients with reduced airway closure.
This maneuver involves the patient holding a tight
breath, swallowing while keeping the airway closed, then
immediately coughing after the swallow. It has been
shown in several studies that the super-supraglottic
swallow has immediate effects on swallowing physiology
[198]. Studies with relevant clinical endpoints are not
available so far [164].
Since patients with neurogenic dysphagia usually have
variable and complex disorders, a combination of vari-
ous adaptive, compensatory and restorative techniques
has often been used in intervention studies. In their sys-
tematic review, Speyer et al. summarized 4 RCTs and 27
non-randomized studies, most of which found a signifi-
cant improvement in swallowing function and other re-
lated endpoints [152]. In a Cochrane Review, updated in
2018, with focus on the treatment of post-stroke dyspha-
gia, the use of behavioral techniques showed no effects
on the key endpoints mortality and global functional
outcomes. However, behavioral swallowing interventions
was associated with a significant improvement in swal-
lowing function and there was a trend for a reduction in
length of hospital stay and a reduction in respiratory
complications [199]. The largest RCT to date has been
performed by Carnaby and co-workers [200] in stroke
patients. The authors randomized 306 patients with
acute dysphagic stroke to a control group receiving
speech therapy according to local conditions, or in two
therapy groups receiving either standardized, low-
frequency or standardized high-frequency dysphagia
therapy. The primary endpoint of the study was the pro-
portion of patients taking a regular oral nutrition six
months after stroke. Although the primary endpoint was
narrowly missed (56% of the control group and 67% of
the two therapy groups achieved the primary endpoint),
standardized behavioral swallowing interventions (either
low or high-intensity) showed a trend to reduce the
combined endpoint of mortality or institutionalization
and significantly reduced the rate of medical complica-
tions and the frequency of bronchopneumonia [200].
In addition, several comprehensive treatment pro-
grams have been evaluated in non-randomized trials.
The McNeill dysphagia treatment protocol improved
swallowing physiology in an observational study [201], as
well as diet and clinical swallowing ability in a case-con-
trol and cohort study [202, 203]. The intensive dysphagia
rehabilitation protocol was tested in a small observational
study and improved the severity of aspiration and level of
oral intake [204]. Similar results were found in a prospect-
ive study recruiting a small cohort of dysphagic geriatric
patients. Here, swallowing function improved after 8
weeks of systematic swallowing treatment [205].
Oral hygiene in patients with neurogenic dysphagia
Recommendation 40: In patients with neurogenic
dysphagia, good oral health should be established to
reduce the risk of pneumonia and, if necessary, con-
sistent oral hygiene should be performed.
Poor oral health in combination with dysphagia has
been identified in particular in stroke and geriatric pa-
tients as a risk factor for aspiration pneumonia [206,
207]. In addition to periodontitis, gingivitis, plaque for-
mation and caries, respiratory pathogens such as
Staphylococcus aureus, Streptococcus pneumoniae, Hae-
mophilus influenzae, Klebsiella oxytoca, Pseudomonas
aeruginosa and Escherichia coli have frequently been de-
tected in the oral cavity of these patients [208]. The as-
piration of bacterial contaminated saliva is therefore
considered to be the main pathogenic mechanism of
pulmonary infections in severely dysphagic patients fed
via a gastric tube [209]. In order to avoid aspiration-
related respiratory infections, interventions to improve
oral health and reduce oral germ load are considered as
therapeutic option in various collectives. Studies in
stroke patients have shown that both, establishing simple
protocols for the oral hygiene and also the use of more
complex procedures for oral and dental cleaning, lead to
an improvement of oral health [210]. In two RCTs the
rate of respiratory infections in the intervention group
was significantly lower than in the control group [211,
212], while another study failed to demonstrate such an
effect [213]. In another RCT, the effect of selective
oral decontamination was evaluated. In this study,
both the pneumonia rate as well as the proportion of
patients being colonized with oral pathogenetic bac-
teria were reduced in the intervention group that re-
ceived non-absorbable antibiotics and antifungals,
while there was no difference in mortality [214]. In
several cohort studies, RCTs and systematic reviews
targeting mixed geriatric collectives and nursing home
residents different forms of oral hygiene (regular
brushing of teeth, chlorhexidine mouth rinses, profes-
sional dental cleaning) also reduced pneumonia rates
[215–219], while a smaller number of studies could
not confirm this effect [220–222]. Consistent oral hy-
giene is also part of the already mentioned "Minimal-
Massive Intervention (MMI)" to avoid aspiration
pneumonia in frail elderly people [161].
Pharmacotherapy of neurogenic dysphagia
Recommendation 41: Before initiating pharmacother-
apy in patients with neurogenic dysphagia, the
Dziewas et al. Neurological Research and Practice            (2021) 3:23 Page 18 of 30
pattern of swallowing impairment should be deter-
mined as precisely as possible.
Recommendation 42: Pharmacological therapies of
neurogenic dysphagia can be considered as a supple-
ment to behavioral swallowing interventions in par-
ticular in patients with a delayed swallow response.
Recommendation 43: Due to the limited evidence
for pharmacological therapeutic approaches, these
therapies should be considered on a case-by-case
basis based on a careful risk-benefit analysis.
Pharmacological treatment of OD involves the use of
drugs that stimulate the neural pathways of deglutition
either on the peripheral sensory level or at different
levels of the central nervous system [20]. Classes of
pharmacological agents that have been evaluated for
their potential to improve disordered swallowing are
TRPV1 agonists (Transient Receptor Potential Cation
Channel Subfamiliy 1), ACE-inhibitors, dopaminergic
agents and Sigma-1 receptor agonists. Currently, the po-
tential of this treatment approach has not been fully ex-
plored. Despite some promising studies focused on
swallowing physiology and a few well-made Proof-of-
Principle-studies, sufficiently large multicenter RCTs
with clinically relevant endpoints are not available for
any of the mentioned pharmaceuticals.
TRPV1 agonists, in particular capsaicinoids and piper-
ine, stimulate TRPV1 receptors expressed at free nerve
endings of the superior laryngeal nerve and the glosso-
pharyngeal nerve [223]. In several case-control studies,
observation studies and three RCTs in different patient
collectives, it has been shown that these substances in-
crease the safety of the swallowing by shortening the la-
tency of the swallowing reflex, by shortening laryngeal
vestibule closure time and improving laryngeal elevation
[71, 224–226]. In another RCT, the administration of
capsaicin was associated with an increase in salivary sub-
stance P and an improvement in subjective swallowing
capacity [227]. Finally, an RCT in stroke patients using
capsaicin in addition to defined dietary and behavioral
interventions showed that clinically evaluated swallowing
function showed better recovery in patients receiving
capsaicin compared to placebo after a 3-week treatment
period [228]. However, studies with clinically relevant
endpoints are still missing.
Disease-related loss of dopaminergic neurons, e.g. due
to stroke or neurodegenerative diseases, contributes to
the development of neurogenic dysphagia and is particu-
larly associated with a delayed swallowing reflex [229].
Application of L-Dopa has been shown to normalize the
onset of the pharyngeal swallow in a RCT with cross-
over design that recruited patients with post-stroke dys-
phagia [230]. A second RCT, which also recruited
chronic stroke patients, showed that nocturnal aspiration
episodes could be reduced by a treatment with either
amantadine or the dopamine receptor agonist cabergo-
line [231]. Finally, in the largest RCT to date that re-
cruited 163 chronic stroke patients with persistent
dysphagia, Nakagawa and co-workers showed that treat-
ment with 100 mg amantadine per day significantly de-
creased the rate of pneumonia over the study period of
three years [232].
ACE inhibitors are among the most commonly used
antihypertensives. Their typical side effects include a dry
cough caused by a reduced degradation of bradykinin
and substance P. Substance P, which is released by free
nerve endings in the pharynx and larynx, is known to
enhance the swallow and cough reflex and there is evi-
dence that decreased sputum levels of this neurotrans-
mitter are associated with aspiration pneumonia [233].
In accordance with this pathophysiological concept,
ACE inhibitors have been shown to shorten the latency
of the swallowing reflex, increase the spontaneous swal-
lowing frequency and reduce the risk of nocturnal aspir-
ation [234–236]. Although these data suggest that ACE
inhibitors can in principle lead to a strengthening of
protective reflexes, studies targeting clinically relevant
endpoints, in particular aspiration pneumonia, provided
inconsistent results so far. On the one hand, a meta-
analysis considering 5 RCTs and several case-control
studies described a significant reduction in pneumonia
risk associated with ACE inhibitor therapy [237]. On the
other hand, a multicenter RCT randomizing tube-fed
post-stroke patients to 2.5 mg Lisinopril or placebo was
prematurely terminated because of an excess of mortal-
ity in the intervention group. There was no difference in
the incidence of pneumonia [238].
Dextrometorphan (DM) is a weak NMDA receptor an-
tagonist and also a Sigma-1 receptor agonist. Sigma-1
receptors are mainly found in the cerebellum and brain
stem and, in particular, have been detected in bulbar
motor neurons [239]. Probably by using this biochem-
ical pathway, DM in combination with quinidine
(DM/C), which inhibits its degradation, has been
shown to improve pseudobulbar affect disorder in pa-
tients with ALS and MS. In 2010, DM/C was there-
fore approved by the FDA for this indication and in
the following years the use of this drug in everyday
clinical practice was extended to patients with Parkin-
son's disease and dementia [240]. In view of its
pharmacological properties, Smith and colleagues in-
vestigated in a randomized clinical study using a
cross-over design whether DM/C also had an impact
on dysphagia in patients with ALS and clinically rele-
vant bulbar symptoms [241]. As a main result, this
study showed a significant improvement of subject-
ively perceived swallowing function (primary end-
point), while no effect on objective parameters of
swallowing function were found (secondary endpoint).
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Neurostimulation
Recommendation 44: Before initiating dysphagia
treatment with a neurostimulation approach, the pat-
tern of swallowing impairment should be determined
as precisely as possible.
Recommendation 45: All neurostimulation methods
should be used as a supplement to the behavioral
swallowing therapy.
Recommendation 46: Due to limited data, neurosti-
mulation methods in principle should be used in
clinical trials or registries.
Recommendation 47: Pharyngeal electrical stimula-
tion (PES) should be used to treat dysphagia in tra-
cheotomized stroke patients with supratentorial
lesion. Participation in prospective clinical registries
is recommended.
In recent years, various methods of peripheral (neuro-
muscular electrical simulation (NMES), pharyngeal elec-
trical stimulation (PES)) and central neurostimulation
(repetitive transcranial magnetic stimulation (rTMS),
transcranial direct current stimulation (tDCS)) have
reached a stage of development that makes their use in
the clinical context outside from controlled trials in-
creasingly conceivable in the near future [26]. Although
these methods have been tested in a number of studies
and in different patient populations of late, larger multi-
center RCTs with clinically relevant endpoints are
needed for a final assessment of their respective
effectiveness.
Neuromuscular electrical simulation (NMES) stimu-
lates sensory or motor nerve fibers involved in swallow-
ing transcutaneously. Its mechanism of action is thought
to include accelerating the development of muscle
strength and promoting central nervous system recovery.
NMES is commonly used in addition to behavioral swal-
lowing therapy. Meta-analyses of predominantly smaller
randomized and non-randomized studies showed a
moderate effect of NMES on swallowing function and
level of diet [242–245]. These findings have been con-
firmed in two RCTs. Park and co-workers showed im-
proved hyoid-movement in subacute stroke patients
after treatment with NMES in combination with effortful
swallowing compared to effortful swallowing alone
[246]. Terre and Mearin found improved feeding status
in patients with OD after stroke or traumatic brain in-
jury when being exposed to NMES and conventional
swallowing therapy compared to conventional swallow-
ing therapy alone [247]. Another scientifically sound
RCT, however, showed no additional benefit of sensory
or motor NMES when supplementing behavioral swal-
lowing therapy in patients with Parkinson's disease re-
lated dysphagia. Regardless of whether the patients received
behavioral swallowing therapy alone or combined with sen-
sory or motor NMES, a similar improvement of a variety of
oral and pharyngeal phase parameters were demonstrated
by instrumental swallowing assessment [248].
In pharyngeal electrical stimulation (PES), the tongue
base and the back of the pharyngeal wall are electrically
stimulated via a transnasally inserted feeding tube hous-
ing a pair of bipolar ring electrodes. PES induces neuro-
plasticity within the swallowing network by targeting the
pharyngeal motor and sensory cortices and possibly also
working on the peripheral sensory afferent system.
Muscle contraction, in contrast to NMES focusing on
pure muscle strengthening, is not the aim of treatment.
In smaller RCTs in dysphagic stroke patients and pa-
tients with neurogenic dysphagia due to multiple scler-
osis, PES has been shown to improve dysphagia and, in
some cases, even shorten the times to hospital discharge
[249–251]. The STEPS study, however, a large multicen-
ter RCT investigating the effect of PES for the treatment
of dysphagia in acute and subacute stroke patients,
showed no effect of the intervention compared to sham
stimulation [252]. On the other hand, the multi-center
PHAST-TRAC study, which recruited severely dyspha-
gic, tracheotomized stroke patients with supratentorial
lesions, showed a significant benefit of PES. While in the
therapy group almost 50% of patients could be decannu-
lated after a three-day PES intervention, in the control
group a spontaneous remission of dysphagia allowing
the patients to be decannulated, was witnessed in only
9% of the patients [126]. A meta-analysis that considered
the results of a single center RCT in addition to PHAS
T-TRAC [253], confirmed this therapeutic effect [126].
Both rTMS (repetitive transcranial magnetic stimula-
tion) and tDCS (transcranial direct current stimulation)
have been used for direct, non-invasive stimulation of
the swallowing network with the aim of influencing the
functionally relevant level of excitability and activity
[254]. In the meantime, a large number of smaller
RCTs and cohort studies were summarized in several
meta-analyses, which were able to show a moderate
but persistent therapeutic effect on swallowing func-
tion for both neurostimulation methods [245, 255–
257]. In the largest single-center RCT on this topic to
date, contralesional tDCS in acute dysphagic stroke
patients was not only associated with an improvement
in dysphagia, but also a neurophysiological detectable
modulation of the swallowing network was found in
spatial proximity to stimulation [258]. Apart from
post-stroke dysphagia, a positive effect of transcranial
stimulation on swallowing function was also demon-
strated in MS patients with strategic brain stem lesion
[259, 260]. In addition to the supratentorial stimula-
tion evaluated in these studies, there is also initial
evidence that cerebellar stimulation can also contrib-
ute to a reorganization of the swallowing network
and improve swallowing function [261, 262].
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Treatment of hypersalivation in patients with neurogenic
dysphagia
Recommendation 48: Debilitating hypersalivation in
patients with neurogenic dysphagia can be treated
with botulinum toxin injections into the salivary
glands and/or anticholinergic drugs.
Recommendation 49: If pharmacological treatment
does not provide adequate symptom control or if side
effects prevent from its continuation, radiotherapy of
the salivary glands may be considered.
The treatment of hypersalivation, a condition which is
highly important for the management of patients with
neurogenic dysphagia, has been comprehensively elabo-
rated in the S2k guidelines “Hypersalivation”. This
guideline was developed by the German Society of Oto-
laryngology, Head and Neck Surgery (DGHNO KHC)
with the participation of other professional societies and
associations (DGPP, DGSS, DGPPN, DGN, DGP, DPV,
DNP, DEGRO, DGMKG) and was updated in 2019 [27].
Therefore, a comprehensive presentation of this topic is
omitted here and the available therapeutic options are
summarized referring to the guideline above.
The pharmacological therapy of hypersalivation con-
sists on the one hand in the inhibition of the salivary
glands by anticholinergic muscarin-receptor antagonists.
These agents can be administered orally, intravenously,
by intramuscular injection, transdermally or quasi local
(e.g. sublingual application of drops or spray). In
Germany, atropine, scopolamine, and glycopyrrolate are
mainly used. The application of these substances in
adults is off-label, only glycopyrrolate has been approved
for the symptomatic treatment of severe hypersalivation
in children from 3 years on and adolescents throughout
Europe in 2016. On the other hand, the cholinergic neu-
roglandular transmission of the salivary glands can be
reversible and significantly reduced by the intraglandular
injection of botulinum toxin into the large salivary
glands. After successful completion of an RCT in
which 184 patients with typical (70.7%) or atypical
(8.7%) Parkinson syndromes, stroke (19%) or trau-
matic brain injury (2.7%) were included, Incobotuli-
num toxin A has been approved in Europe for the
treatment of hypersalivation in adults irrespective of
the underlying etiology in 2019 [263, 264]. Radiother-
apy can also be used for the treatment of hypersaliva-
tion in individual cases, e.g. if the treatment with
anticholinergic drugs or the injection therapy with
botulinum toxin do not provide sufficient symptom
control or repeated injections are not feasible. While
the fundamental and long-lasting efficacy of external
irradiation of the salivary glands has been convin-
cingly demonstrated, the possible side effects as well
as the inherent carcinogenic potential must be taken
into account [27].
Minimally invasive and surgical therapies
Recommendation 50: For the treatment of cricophar-
yngeal dysfunction with impaired opening of the
UES, cricopharyngeal myotomy (open or endoscopic),
dilatation (by balloon or bougie) and botulinum toxin
injection (transcutaneous or endoscopic) are
considered.
Recommendation 51: The indication should be
made by a multi-professional team of experts. The
procedure should only be carried out at specialized
centers.
Recommendation 52: The indication for interven-
tional or surgical treatment of cricopharyngeal dys-
function and impaired opening disorder of the UES
in the context of neurogenic dysphagia should con-
sider the following criteria:
1. The diagnosis is based on VFSS and HRM.
2. The phenotype and etiology of dysphagia have
been clarified.
3. A sufficiently long (approx. 1 year) conservative
therapy (treatment of the underlying disease;
swallowing therapy by Shaker exercise,
Mendelsohn maneuvers, EMST) has not been
successful.
4. A refractory gastro-oesophageal reflux has been
ruled out.
5. A sufficient hyolaryngeal elevation is present.
Recommendation 53: For the treatment of therapy-
refractory glottal closure insufficiency, minimal-
invasive surgical procedures for medialization of the
vocal folds may be chosen. This treatment aims at
improving cough and reducing the risk of aspiration.
Minimal-invasive and surgical therapy procedures can
be applied for the treatment of severe opening disorders
of the UES, if this disorder is relevant to the overall im-
pression of the swallowing disorder. In case of crico-
pharyngeal myotomy the muscles forming the UES
(cricopharyngeal muscle, inferior pharyngeal constrictor
muscle as well as the upper striated muscles of the
oesophagus) either can be cut through in the longitu-
dinal direction by open or endoscopic access [92, 265].
Minimal-invasive treatment options consist of the dilata-
tion of the UES (with a balloon or bougie) [266] and the
endoscopic or transcutaneous injection of botulinum
toxin [267]. These procedures have so far been tested in
patients with inclusion body myositis, oculopharyngeal
muscle dystrophy, multiple sclerosis, amyotrophic lateral
sclerosis, stroke and M. Parkinson. As consistently sum-
marized in several reviews and two Cochrane analyses,
these therapeutic options have mainly been evaluated
within retrospective, uncontrolled case series [92, 265,
268]. Only in one randomized pilot study balloon
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dilatation was compared with laser myotomy in 8 pa-
tients. Both treatments resulted in an increase in the
diameter of the UES and a subjective improvement of
dysphagia [269]. In a systematic review summarizing the
results of 32 studies, available therapeutic options were
compared in terms of effectiveness and side effects
[270]. Weighted average success rates of each interven-
tion were 78% for myotomy (84% for endoscopic myot-
omy and 71% for open surgery), 73% for dilatation and
49% for botulinum toxin injection. The weighted average
complication rates were 7% for myotomy (2% for endo-
scopic myotomy and 11% for open surgery), 5% for dila-
tation and 4% for botulinum toxin injection.
Complications included fistula, supraglottic edema, med-
iastinitis, retropharyngeal hematoma, oesophageal injur-
ies, laryngospasm and severe bleeding [270]. Although
these figures do not allow for a reliable comparison of
the different methods due to limited data, they neverthe-
less indicate that all of the therapeutic options basically
may be employed. Since the indication is difficult and
side effects can be serious, even life-threatening, these
interventions should only be performed in specialized
centers involving surgeons, gastroenterologists, otolaryn-
gologists and neurologists with appropriate relevant ex-
pertise. The following expert recommendations can be
considered in this context. 1. Any intervention targeting
the UES should be performed after comprehensive diag-
nostics including VFSS and HRM; 2. An etiological clas-
sification of the underlying dysphagia should have been
made; 3. A sufficiently long (approx. 1 year) conservative
therapy (treatment of the underlying disease; swallowing
therapy by Shaker exercise, Mendelsohn maneuvers,
EMST) should have been carried out and found to be in-
effective; 4. The presence of a therapy-refractory reflux
should have been ruled out; 5. A sufficient hyolaryngeal
elevation should be present.
Minimally invasive and surgical procedures are also
helpful for the treatment of glottal insufficiency (GI).
In addition to improving the quality of voice, these
treatments may also lead to an improvement in swal-
lowing safety. Vocal fold palsy due to the affection of
the vagal nerve and its branches as well as pro-
nounced vocal fold atrophies, which occur e.g. in M.
Parkinson or ALS [271], can cause GI that causes an
impairment of laryngeal protective functions [272].
Aspiration and reduced cough strength with subse-
quent impaired laryngeal and bronchial clearing are
likely consequences [273]. In the case of brain stem
or vagal nerve lesions, the risk of aspiration is par-
ticularly high due to the associated UES dysfunction
and severe sensory loss [272].
If, despite sufficient long and intensive speech therapy,
no sufficient improvement of GI is achieved, surgical
medialization techniques can be used as support. As a
consequence of medializing the vocal fold, the laryngeal
protective function improves by preventing aspiration
and increasing cough strength [274]. The treatment
strategy of a persistent GI with aspiration essentially
comprises of vocal fold augmentation, which is per-
formed in local anaesthesia and office-based with tem-
porary or permanent injectates [275, 276]. In case of
larger GIs, thyroplasty, in which the vocal fold is media-
lized from the outside through the laryngeal framework,
e.g. with a silicone wedge, goretex or titanium, has been
established [277].
Although glottic narrowing interventions have been
successfully used for many years to improve voice and
swallowing, there are no randomized trials or systematic
reviews investigating their effectiveness in neurogenic
dysphagia. However, the results of the published case
series and smaller case studies mostly show that the
medialization techniques improve not only the subjective
but also the objective swallowing capacity by reducing
aspiration and improving the cough [278, 279]. In vocal
fold augmentation, the complications are generally rare
and mainly include laryngeal edema, material intoler-
ance, overcorrections and bleeding. Since with the help
of laryngoscopy indicating this treatment is simple and
the procedure is gentle and quick, the medialization of
the vocal fold can be a useful supplement in the therapy
of neurogenic dysphagia with GI.
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